Cellectis Competitors and Similar CompaniesClear all
Polymun's competitors and similar companies include Allogene Therapeutics and UCB.
 Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1992 | Founding Date 2018 | Founding Date 1928 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Klosterneuburg, AT HQ | Locations South San Francisco, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 80 | Employees 2263% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 585.5 m | Valuation ($) 34.3 b |
Financial | |||
Net income | Net income N/A | Net income ($190.9m) (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Allogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View companyUCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company